MedTrace Logo

SensoGrip - a Pressuresensitive Writing System

NCT05014854 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-12-02

No results posted yet for this study

Summary

The presented study deals with the technically supported, fine motor adjustment of finger and tip pressure in children with graphomotor difficulties by means of a pressure-sensitive pen and a corresponding tablet app. Three target groups (occupational therapists, children, and legal guardians, n=15 each) will be recruited and included in a mixed-methods study. The guiding research questions deal with the effects, acceptance and usability of the applied system.

The active phase of the study covers a period of three months. Expected results lie primarily in the area of improving the target group writing skills (children) and improving opportunities in occupational therapy.

Conditions

  • Developmental Delay in Fine Motor Function (Disorder)

Interventions

DEVICE

Usage of the SensoGrip-System comprised of the SensoGrip pen and a tablet app.

Intervention consists of the usage of the SensoGrip-System in at least 6 and up to 8 therapy session together with the participating child. It is assumed that the standard frequency of therapy sessions is once a week, resuming in a span of 6-8 weeks. 10 minutes of every therapy session during the intervention phase must involve the application of the SensoGrip-System. Sample exercises are made available, therapists can freely choose which exercises are used.

Sponsors & Collaborators

  • FH Campus Wien, University of Applied Sciences

    lead OTHER

Principal Investigators

  • Franz Werner, Dr. · FH Campus Wien - University of Applied Life Sciences

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-08
Primary Completion
2021-10-29
Completion
2021-10-29

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05014854 on ClinicalTrials.gov